相关实验视频
Updated: Jun 23, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
11.9K
作为向化疗剂的奎纳林衍生物
1Pharmaceutical Sciences, Fakeeh College for Medical Sciences, Jeddah, SAU.
Cureus
|June 20, 2024
概括
由于有毒化疗,需要新的向癌症药物. 基纳林衍生物通过抑制二叶酸减少酶和聚基酶等关键分子标,显示出有前途的潜力,为更有选择性的癌症治疗提供了潜在的潜力.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的化疗药物具有显著的毒性和有限的选择性,导致治疗耐药性.
- 具有提高选择性和减少副作用的向治疗对于有效的癌症治疗至关重要.
- 基纳素支架是一个特权结构,具有丰富的生物活动的丰富历史.
研究的目的:
- 审查金纳佐林衍生物的化学信息,分子结构,设计和生物活性.
- 突出纳林向癌症中的关键分子机制.
- 为了探索quinazolines作为向抗癌剂的潜力.
主要方法:
- 关于已报告的金纳林衍生物的文献综述.
- 分析化学结构和设计策略.
- 对特定的分子标进行生物活动的评估.
主要成果:
- 基纳林衍生物已经证明对多种癌症点的有效性.
- 确定了二叶酸减少酶的抑制剂,乳腺癌抗性蛋白质,聚- ((ADP-ribose) -聚合酶和素聚合物的抑制剂.
- 该综述详细介绍了各种基纳林抗癌剂的结构-活性关系.
结论:
- 基纳林衍生物代表了针对癌症治疗的一类有前途的化合物.
- 它们抑制关键分子标的能力为克服化疗限制提供了一条途径.
- 对quinazoline设计的进一步研究可以导致新的,更有效的抗癌药物.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
257
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
257
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K

